2016
DOI: 10.1186/s13073-016-0286-z
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer

Abstract: Editorial summarySignatures of mutagenesis provide a powerful tool for dissecting the role of somatic mutations in both normal and pathological processes. Significantly, cancer genomes are dominated by mutation signatures distinct from those that accumulate in normal tissues with age, with potentially important translational implications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 9 publications
(10 reference statements)
0
22
0
Order By: Relevance
“…The TP53 ‐mutated subcohort also displayed the concurrent ongoing accumulation of SI1 along patient aging. SI1 is largely made up of C>T substitutions at CpG dinucleotides, which are the results of an endogenous mutational process initiated by spontaneous deamination of 5‐methylcytosine, enzymatic deamination of cytosine or polymerase errors . The SI3 associated with failure of DNA double‐strand break‐repair by homologous recombination was as well increasing along patient age in the TP53 ‐mutated subcohort.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The TP53 ‐mutated subcohort also displayed the concurrent ongoing accumulation of SI1 along patient aging. SI1 is largely made up of C>T substitutions at CpG dinucleotides, which are the results of an endogenous mutational process initiated by spontaneous deamination of 5‐methylcytosine, enzymatic deamination of cytosine or polymerase errors . The SI3 associated with failure of DNA double‐strand break‐repair by homologous recombination was as well increasing along patient age in the TP53 ‐mutated subcohort.…”
Section: Discussionmentioning
confidence: 99%
“…Mathematical modeling strongly suggests that half or more of somatic passengers mutations in tumors arise before initiation of the tumor, that is, during development and aging . They are classified as either “driver” mutations, which initiate the tumor and confer selected cancer phenotypes, or the far more numerous “passenger” mutations which have minor impact on cell growth and proliferation but they might built strength to cancer progression or confer resistance to the treatments . Indeed, several studies illustrated the ongoing aging‐related process of accumulation of mutations, selection, and clonal expansion .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Resveratrol triggered apoptosis within human T-cell acute lymphoblastic leukemia MOLT-4 cells by abrogating Akt phosphorylation, and subsequently preventing GSK3β from being activated [135]. Similarly, resveratrol induced apoptosis in ovarian, [136] breast, [137] uterine, [138] prostate, [120] and multiple myeloma cells [121], via inhibiting Akt phosphorylation. Chen et al [139] determined that resveratrol inhibited the phosphorylation of PI3K/Akt (i.e., PI3K/Akt inactivation) in prostate cancer cells, resulting in decreased Forkhead box protein (FOXO) activation.…”
Section: Anti-tumor-promotion Activitymentioning
confidence: 99%
“…The advent of next-generation sequencing technologies has enabled large-scale sequencing of all protein-coding exons (whole-exome sequencing) or even whole cancer genomes (whole-genome sequencing) in a single experiment [132][133][134][135][136][137][138]. These sequencing efforts have enabled the identification of many thousands of mutations per cancer which provided sufficient power to detect different mutational patterns or "signatures."…”
Section: Mutational Signatures In Human Cancersmentioning
confidence: 99%